Long-term and zero-order release of basic fibroblast growth factor from heparin-conjugated poly(L-lactide-co-glycolide) nanospheres and fibrin gel.

scientific article

Long-term and zero-order release of basic fibroblast growth factor from heparin-conjugated poly(L-lactide-co-glycolide) nanospheres and fibrin gel. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.BIOMATERIALS.2005.08.030
P698PubMed publication ID16146647

P50authorOju JeonQ58782309
P2093author name stringJi Hyung Chung
Byung-Soo Kim
Sun-Woong Kang
Hee-Won Lim
P433issue8
P1104number of pages10
P304page(s)1598-1607
P577publication date2005-09-16
P1433published inBiomaterialsQ15751139
P1476titleLong-term and zero-order release of basic fibroblast growth factor from heparin-conjugated poly(L-lactide-co-glycolide) nanospheres and fibrin gel
P478volume27

Reverse relations

cites work (P2860)
Q53477371Active blood vessel formation in the ischemic hindlimb mouse model using a microsphere/hydrogel combination system.
Q47427231Arginine functionalization of hydrogels for heparin binding--a supramolecular approach to developing a pro-angiogenic biomaterial
Q92508854Bioactive Medications for the Delivery of Platelet Derivatives to Skin Wounds
Q47165579Bioinspired Heparin Nanosponge Prepared by Photo-crosslinking for Controlled Release of Growth Factors.
Q39291722Co-transplantation of bone marrow-derived mesenchymal stem cells and nanospheres containing FGF-2 improve cell survival and neurological function in the injured rat spinal cord
Q36005075Comparison between heparin-conjugated fibrin and collagen sponge as bone morphogenetic protein-2 carriers for bone regeneration
Q33603057Control growth factor release using a self-assembled [polycation:heparin] complex
Q39754529Controlled and sustained gene delivery from injectable, porous PLGA scaffolds.
Q35162409Controlled protein delivery in the generation of microvascular networks.
Q48009478Controlled release of basic fibroblast growth factor for angiogenesis using acoustically-responsive scaffolds.
Q38068244Controlled release strategies for bone, cartilage, and osteochondral engineering--Part II: challenges on the evolution from single to multiple bioactive factor delivery
Q57337767Critical factors in the design of growth factor releasing scaffolds for cartilage tissue engineering
Q50847623Delivery of a therapeutic protein for bone regeneration from a substrate coated with graphene oxide.
Q47880097Design and characterization of hydrogel nanoparticles with tunable network characteristics for sustained release of a VEGF-mimetic peptide
Q46813976Designing Acellular Injectable Biomaterial Therapeutics for Treating Myocardial Infarction and Peripheral Artery Disease
Q64110064Differentiation of Bone Marrow Mesenchymal Stem Cells into Neural Lineage Cells Induced by bFGF-Chitosan Controlled Release System
Q50440578Effect of a Scaffold Fabricated Thermally from Acetylated PLGA on the Formation of Engineered Cartilage
Q27333474Encapsulation-free controlled release: Electrostatic adsorption eliminates the need for protein encapsulation in PLGA nanoparticles
Q35600150Endogenous repair signaling after brain injury and complementary bioengineering approaches to enhance neural regeneration
Q50949843Engineered adipose tissue formation enhanced by basic fibroblast growth factor and a mechanically stable environment.
Q35645763Enhanced skin wound healing by a sustained release of growth factors contained in platelet-rich plasma
Q39222465Fibrin gels containing GDNF microspheres increase axonal regeneration after delayed peripheral nerve repair
Q38030641From nano- to macro-scale: nanotechnology approaches for spatially controlled delivery of bioactive factors for bone and cartilage engineering
Q51158186Heparin immobilized porous PLGA microspheres for angiogenic growth factor delivery.
Q43952051Heparin-conjugated poly(lactic-co-glycolic acid) nanospheres enhance large-wound healing by delivering growth factors in platelet-rich plasma
Q38643959Heparin-decorated, hyaluronic acid-based hydrogel particles for the controlled release of bone morphogenetic protein 2.
Q82322545Heparin-functionalized collagen matrices with controlled release of basic fibroblast growth factor
Q46410876Heparin-modified dendrimer cross-linked collagen matrices for the delivery of basic fibroblast growth factor (FGF-2).
Q36400508Human Urine-derived Stem Cells Seeded Surface Modified Composite Scaffold Grafts for Bladder Reconstruction in a Rat Model
Q35639514Improved spinal fusion efficacy by long-term delivery of bone morphogenetic protein-2 in a rabbit model
Q50518747In situ cardiomyogenic differentiation of implanted bone marrow mononuclear cells by local delivery of transforming growth factor-β1.
Q38135949Incorporation of heparin into biomaterials
Q37960809Injectable and biodegradable hydrogels: gelation, biodegradation and biomedical applications.
Q45919200Loading of VEGF to the heparin cross-linked demineralized bone matrix improves vascularization of the scaffold.
Q50230512Localized delivery of methylprednisolone sodium succinate with polymeric nanoparticles in experimental injured spinal cord model
Q37562012Locally delivered growth factor enhances the angiogenic efficacy of adipose-derived stromal cells transplanted to ischemic limbs
Q39083233Medical application of glycosaminoglycans: a review
Q36198788Microsecond-pulsed dielectric barrier discharge plasma stimulation of tissue macrophages for treatment of peripheral vascular disease
Q38152204Molecular engineering of glycosaminoglycan chemistry for biomolecule delivery
Q42114375Multifunctional nanoscale strategies for enhancing and monitoring blood vessel regeneration
Q47700878Multilayered pore-closed PLGA microsphere delivering OGP and BMP-2 in sequential release patterns for the facilitation of BMSCs osteogenic differentiation
Q37470319Nanoparticulate systems for growth factor delivery
Q35105415Nanospheres delivering the EGFR TKI AG1478 promote optic nerve regeneration: the role of size for intraocular drug delivery
Q36748503Nanotechnology in the diagnosis and management of heart, lung and blood diseases.
Q41500114Novel Method for Loading Microporous Ceramics Bone Grafts by Using a Directional Flow.
Q37471639Potential of hydrogels based on poly(ethylene glycol) and sebacic acid as orthopedic tissue engineering scaffolds
Q39273739Protein based therapeutic delivery agents: Contemporary developments and challenges
Q37439946Release characteristics and osteogenic activity of recombinant human bone morphogenetic protein-2 grafted to novel self-assembled poly(lactide-co-glycolide fumarate) nanoparticles
Q50962974Release rate controls biological activity of nerve growth factor released from fibrin matrices containing affinity-based delivery systems.
Q37841416Standardization of models and methods used to assess nanoparticles in cardiovascular applications
Q38537491Strategies for the chemical and biological functionalization of scaffolds for cardiac tissue engineering: a review
Q43048909Synthesis and characterization of Poloxamer 188-grafted heparin copolymer
Q34377496Synthesis and characterization of UPPE-PLGA-rhBMP2 scaffolds for bone regeneration
Q30449821Targets and delivery methods for therapeutic angiogenesis in peripheral artery disease
Q37195004The effect of the local delivery of platelet-derived growth factor from reactive two-component polyurethane scaffolds on the healing in rat skin excisional wounds
Q37909452The use of micro- and nanospheres as functional components for bone tissue regeneration
Q58909325Therapeutic Angiogenesis of PLGA-Heparin Nanoparticle in Mouse Ischemic Limb
Q38037091Therapeutic angiogenesis for treating cardiovascular diseases
Q55638524Therapeutic neovascularization promoted by injectable hydrogels.
Q36294602Transplantation of cord blood mesenchymal stem cells as spheroids enhances vascularization
Q42071394Tunable Controlled Release of Bioactive SDF-1α via Protein Specific Interactions within Fibrin/Nanoparticle Composites

Search more.